戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  an incidental finding of a periampullary or pancreatic mass.
2  to partial pancreatic agenesis, diminishing pancreatic mass.
3 itional knockout background severely reduced pancreatic mass.
4 such as the detection of liver metastases or pancreatic masses.
5 216 HRIs (42%) were found to have at least 1 pancreatic mass (84 cystic, 3 solid) or a dilated pancre
6                            Thus, islet cell, pancreatic mass and pancreatic morphogenesis are regulat
7 ressed in Pdx1+ pancreatic progenitors, both pancreatic mass and proliferation of progenitors are red
8                                The increased pancreatic mass and protein content was independent of c
9 nts were also less likely to have a discrete pancreatic mass at operation, more likely to have a diff
10 n abrogated the GLP-1R-dependent increase in pancreatic mass but had no effect on the robust inductio
11    Incidentally discovered periampullary and pancreatic masses comprise a substantial proportion of p
12 rs metabolic outcomes support the primacy of pancreatic mass in determining glucose homeostasis, but
13 = 14) reveals an approximately 40% increased pancreatic mass in DM treated with incretin therapy, wit
14                                              Pancreatic mass in R6/2 mice was the same as controls, a
15 uces protein synthesis, leading to increased pancreatic mass, independent of changes in DNA content o
16 ferentiation of inflammatory from neoplastic pancreatic mass lesions.
17 come the procedure of choice for biopsies of pancreatic mass lesions.
18 mM, p=0.009) with islet cytoarchitecture and pancreatic mass of islet beta-cells that were indistingu
19                Contrary to expectations, the pancreatic mass of Pdx1-Cre;Mst1(-/-);Mst2(fl/fl) mice w
20 patients were less likely to have a discrete pancreatic mass on CT and more likely to have CT finding
21 ents (28%) had indeterminate or unrecognized pancreatic masses on CT clarified with 18FDG-PET.
22 e consecutive patients referred for possible pancreatic mass underwent CT with either a standard or s
23                           In addition, fetal pancreatic mass was enlarged by 42%, with a 12-fold incr
24  (98% [95% CI, 91% to 100%]) for detecting a pancreatic mass was greater than that of CT (86% [CI, 77
25                                   Changes in pancreatic mass were paralleled by protein and DNA conte
26 ic ultrasonography-guided FNA for diagnosing pancreatic masses were determined.
27  play a valuable role in the evaluation of a pancreatic mass when results on other biopsy methods are